{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:04:30Z","timestamp":1791615870372,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41232-9","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:03:45Z","timestamp":1772539425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["AI fragmentation-based optimization of Sorafenib derivatives targeting VEGFR2 for angiogenesis-related pathologies: a structure-based in-silico study"],"prefix":"10.1038","volume":"16","author":[{"given":"Deniz","family":"Inan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Karage\u00e7ili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"41232_CR1","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1161\/ATVBAHA.119.312749","volume":"39","author":"A Martowicz","year":"2019","unstructured":"Martowicz, A. et al. Endothelial \u03b2-Catenin signaling supports postnatal brain and retinal angiogenesis by promoting sprouting, tip cell formation, and VEGFR (vascular endothelial growth factor receptor) 2 expression. Arterioscler. Thromb. Vasc. Biol. 39, 2273\u20132288. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312749 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"41232_CR2","doi-asserted-by":"publisher","first-page":"104146","DOI":"10.1016\/j.mvr.2021.104146","volume":"136","author":"H Dan","year":"2021","unstructured":"Dan, H. et al. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo. Microvasc. Res. 136, 104146. https:\/\/doi.org\/10.1016\/j.mvr.2021.104146 (2021).","journal-title":"Microvasc. Res."},{"key":"41232_CR3","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","volume":"7","author":"SM Wilhelm","year":"2008","unstructured":"Wilhelm, S. M. et al. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol. Cancer Ther. 7, 3129\u20133140. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0013 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"41232_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/emboj\/18.2.363","volume":"18","author":"M Meyer","year":"1999","unstructured":"Meyer, M. et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR\u20102 (KDR) but not VEGFR\u20101 (Flt\u20101) receptor tyrosine kinases. EMBO J. 18, 363\u2013374. https:\/\/doi.org\/10.1093\/emboj\/18.2.363 (1999).","journal-title":"EMBO J."},{"key":"41232_CR5","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.3390\/ijms262110431","volume":"26","author":"A Papapanagiotou","year":"2025","unstructured":"Papapanagiotou, A. et al. The Role of Angiogenetic Factors in Preeclampsia. Int. J. Mol. Sci. 26, 10431 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"41232_CR6","doi-asserted-by":"crossref","unstructured":"Adnane, L., Trail, P. A., Taylor, I. & Wilhelm, S. M. in Methods in Enzymology Vol. 407 597\u2013612Academic Press, (2006).","DOI":"10.1016\/S0076-6879(05)07047-3"},{"key":"41232_CR7","doi-asserted-by":"publisher","first-page":"13907","DOI":"10.1038\/s41598-023-40832-z","volume":"13","author":"RMM El-Hazek","year":"2023","unstructured":"El-Hazek, R. M. M., Zaher, N. H., El-Gazzar, M. G. M., Fadel, N. A. & El-Sabbagh, W. A. Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact. Sci. Rep. 13, 13907. https:\/\/doi.org\/10.1038\/s41598-023-40832-z (2023).","journal-title":"Sci. Rep."},{"key":"41232_CR8","doi-asserted-by":"publisher","first-page":"33384","DOI":"10.1039\/D4RA05244G","volume":"14","author":"PJ Chaudhari","year":"2024","unstructured":"Chaudhari, P. J., Nemade, A. R. & Shirkhedkar, A. A. Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents. RSC Adv. 14, 33384\u201333417. https:\/\/doi.org\/10.1039\/D4RA05244G (2024).","journal-title":"RSC Adv."},{"key":"41232_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s42004-025-01542-x","volume":"8","author":"G Platzer","year":"2025","unstructured":"Platzer, G., Mayer, M., McConnell, D. B. & Konrat, R. NMR-driven structure-based drug discovery by unveiling molecular interactions. Commun. Chem. 8, 167. https:\/\/doi.org\/10.1038\/s42004-025-01542-x (2025).","journal-title":"Commun. Chem."},{"key":"41232_CR10","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.3390\/ijms26052192","volume":"26","author":"IM Buzatu","year":"2025","unstructured":"Buzatu, I. M. et al. A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy. Int. J. Mol. Sci. 26, 2192 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"41232_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/07391102.2023.2198039","volume":"42","author":"S Banerjee","year":"2024","unstructured":"Banerjee, S. et al. Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: A cross-validated approach of ligand-based and structure-based molecular modeling studies. J. Biomol. Struct. Dynamics. 42, 1047\u20131063. https:\/\/doi.org\/10.1080\/07391102.2023.2198039 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"41232_CR12","doi-asserted-by":"publisher","unstructured":"Li, Q. Application of Fragment-Based Drug Discovery to Versatile Targets. Front. Mol. Biosci. 7\u20132020. https:\/\/doi.org\/10.3389\/fmolb.2020.00180 (2020).","DOI":"10.3389\/fmolb.2020.00180"},{"key":"41232_CR13","doi-asserted-by":"crossref","unstructured":"Velankar, S., Burley, S. K., Kurisu, G., Hoch, J. C. & Markley, J. L. The protein data bank archive. Structural Proteomics: High-Throughput Methods, 3\u201321 (2021).","DOI":"10.1007\/978-1-0716-1406-8_1"},{"key":"41232_CR14","doi-asserted-by":"publisher","first-page":"1493165","DOI":"10.3389\/fchem.2024.1493165","volume":"12","author":"M Hussain","year":"2024","unstructured":"Hussain, M. et al. Computational modeling of cyclotides as antimicrobial agents against Neisseria gonorrhoeae PorB porin protein: Integration of docking, immune, and molecular dynamics simulations. Front. Chem. 12, 1493165 (2024).","journal-title":"Front. Chem."},{"key":"41232_CR15","doi-asserted-by":"publisher","first-page":"26405","DOI":"10.1038\/s41598-024-77664-4","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy. Sci. Rep. 14, 26405 (2024).","journal-title":"Sci. Rep."},{"key":"41232_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 2, 1511\u20131519 (1993).","journal-title":"Protein Sci."},{"key":"41232_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1142\/S2737416523500631","volume":"23","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. Assessment of Melia azedarach plant extracts activity against hypothetical protein of mycobacterium tuberculosis via GC-MS analysis and in-silico approaches. J. Comput. Biophys. Chem. 23, 299\u2013320 (2024).","journal-title":"J. Comput. Biophys. Chem."},{"key":"41232_CR18","doi-asserted-by":"publisher","first-page":"btae552","DOI":"10.1093\/bioinformatics\/btae552","volume":"40","author":"F Mehryary","year":"2024","unstructured":"Mehryary, F., Nastou, K., Ohta, T., Jensen, L. J. & Pyysalo, S. STRING-ing together protein complexes: Corpus and methods for extracting physical protein interactions from the biomedical literature. Bioinformatics 40, btae552 (2024).","journal-title":"Bioinformatics"},{"key":"41232_CR19","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"41232_CR20","doi-asserted-by":"publisher","first-page":"24565","DOI":"10.1038\/s41598-024-82302-0","volume":"15","author":"B Asrar","year":"2025","unstructured":"Asrar, B., Ali, N., Ali, I. & Naveed, M. In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA. Sci. Rep. 15, 24565 (2025).","journal-title":"Sci. Rep."},{"key":"41232_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1021\/acs.jcim.3c01776","volume":"64","author":"M Torrens-Fontanals","year":"2024","unstructured":"Torrens-Fontanals, M., Tourlas, P., Doerr, S. & De Fabritiis, G. PlayMolecule Viewer: A toolkit for the visualization of molecules and other data. J. Chem. Inf. Model. 64, 584\u2013589 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"41232_CR22","doi-asserted-by":"crossref","unstructured":"Ali, N., Asrar, B. & Ahmad, S. A. I. Fragment Based Optimization of Saffron and Chamomile Phytochemicals as Aryl Hydrocarbon Receptor Inhibitors for Dementia Therapy an Integrated Computational Approach. Computational Biology Chemistry, 108606 (2025).","DOI":"10.1016\/j.compbiolchem.2025.108606"},{"key":"41232_CR23","doi-asserted-by":"crossref","unstructured":"Pol\u00e1k, L. et al. PrankWeb 4: A modular web server for protein\u2013ligand binding site prediction and downstream analysis. Nucleic Acids Research, gkaf421 (2025).","DOI":"10.1093\/nar\/gkaf421"},{"key":"41232_CR24","unstructured":"Jejurikar, B. L. & Rohane, S. H. Drug designing in discovery studio. (2021)."},{"key":"41232_CR25","doi-asserted-by":"publisher","first-page":"e1005659","DOI":"10.1371\/journal.pcbi.1005659","volume":"13","author":"P Eastman","year":"2017","unstructured":"Eastman, P. et al. OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. PLoS Comput. Biol. 13, e1005659. https:\/\/doi.org\/10.1371\/journal.pcbi.1005659 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"41232_CR26","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss\u2010PdbViewer: A historical perspective. Electrophoresis 30, S162\u2013S173 (2009).","journal-title":"Electrophoresis"},{"key":"41232_CR27","first-page":"1000","volume":"10550","author":"R Huey","year":"2012","unstructured":"Huey, R., Morris, G. M. & Forli, S. Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. Scripps Res. Inst. Mol. Graphics Lab. 10550, 1000 (2012).","journal-title":"Scripps Res. Inst. Mol. Graphics Lab."},{"key":"41232_CR28","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-024-51954-3","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. The natural breakthrough: Phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3. Sci. Rep. 14, 1529 (2024).","journal-title":"Sci. Rep."},{"key":"41232_CR29","unstructured":"Pawar, R. P. & Rohane, S. H. Role of autodock vina in PyRx molecular docking. (2021)."},{"key":"41232_CR30","doi-asserted-by":"publisher","first-page":"15906","DOI":"10.1038\/s41598-025-00937-z","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed, M. et al. Exploring the therapeutic potential of Thymus vulgaris ethanol extract: A computational screening for antimicrobial compounds against COVID-19 induced mucormycosis. Sci. Rep. 15, 15906 (2025).","journal-title":"Sci. Rep."},{"key":"41232_CR31","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake, P., Bolz, S. N., Linnemann, K. & Schroeder, M. PLIP 2025: Introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic Acids Res. 53, W463\u2013W465. https:\/\/doi.org\/10.1093\/nar\/gkaf361 (2025).","journal-title":"Nucleic Acids Res."},{"key":"41232_CR32","doi-asserted-by":"crossref","unstructured":"Rahman, S. U. et al. Innovative Phytochemicals Based In-Silico Drug Design and Molecular Dynamics Simulation Targeting Norovirus Induced Gastroenteritis. Journal Mol. Structure, 141733 (2025).","DOI":"10.1016\/j.molstruc.2025.141733"},{"key":"41232_CR33","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"41232_CR34","doi-asserted-by":"crossref","unstructured":"Myung, Y., de S\u00e1, A. G. & Ascher, D. B. Deep-PK: Deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Research, gkae254 (2024).","DOI":"10.1093\/nar\/gkae254"},{"issue":"1\u20133","key":"41232_CR35","first-page":"6","volume":"62, 3","author":"DR Koes","year":"2018","unstructured":"Koes, D. R. The Pharmit backend: A computer systems approach to enabling interactive online drug discovery. IBM J. Res. Dev. 62, 3: (1\u20133), 6 (2018).","journal-title":"IBM J. Res. Dev."},{"key":"41232_CR36","doi-asserted-by":"publisher","first-page":"24906","DOI":"10.1038\/s41598-025-07574-6","volume":"15","author":"N Ali","year":"2025","unstructured":"Ali, N., Akbar, R., Saleem, A., Ali, A. & Ali A. AI based natural inhibitor targeting RPS20 for colorectal cancer treatment using integrated computational approaches. Sci. Rep. 15, 24906 (2025).","journal-title":"Sci. Rep."},{"key":"41232_CR37","doi-asserted-by":"publisher","first-page":"13055","DOI":"10.1039\/D1CP00215E","volume":"23","author":"S Kashefolgheta","year":"2021","unstructured":"Kashefolgheta, S., Wang, S., Acree, W. E. & H\u00fcnenberger, P. H. Evaluation of nine condensed-phase force fields of the GROMOS, CHARMM, OPLS, AMBER, and OpenFF families against experimental cross-solvation free energies. Phys. Chem. Chem. Phys. 23, 13055\u201313074 (2021).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"41232_CR38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.jiph.2023.07.011","volume":"16","author":"M Zaheer","year":"2023","unstructured":"Zaheer, M., Ali, N., Javed, H., Munir, R. & Jamil, N. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach. J. Infect. Public Health. 16, 1544\u20131555 (2023).","journal-title":"J. Infect. Public Health"},{"key":"41232_CR39","first-page":"2770","volume":"12","author":"Y Pang","year":"2022","unstructured":"Pang, Y. et al. Adverse events of sorafenib in hepatocellular carcinoma treatment. Am. J. Cancer Res. 12, 2770\u20132782 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"41232_CR40","doi-asserted-by":"publisher","unstructured":"Mou, L. et al. Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials. Front. Oncol. 11\u20132021 https:\/\/doi.org\/10.3389\/fonc.2021.752725 (2021).","DOI":"10.3389\/fonc.2021.752725"},{"key":"41232_CR41","doi-asserted-by":"publisher","first-page":"14477","DOI":"10.1039\/D5RA01223F","volume":"15","author":"WE Elgammal","year":"2025","unstructured":"Elgammal, W. E. et al. New nicotinamide\u2013thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: Design, synthesis and in silico and in vitro evaluation. RSC Adv. 15, 14477\u201314498 (2025).","journal-title":"RSC Adv."},{"key":"41232_CR42","unstructured":"Wasai, S. et al. Unveiling Novel Vegfr-2 Inhibitors: Qsar Modeling, Molecular Docking, Md and Mm-Gbsa Calculations, Pharmacokinetics Profiling and Dft Studies. Molecular Docking, Md and Mm-Gbsa Calculations, Pharmacokinetics Profiling and Dft Studies."},{"key":"41232_CR43","doi-asserted-by":"publisher","first-page":"101889","DOI":"10.1016\/j.jsps.2023.101889","volume":"32","author":"A Mahal","year":"2024","unstructured":"Mahal, A. et al. Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents. Saudi Pharm. J. 32, 101889. https:\/\/doi.org\/10.1016\/j.jsps.2023.101889 (2024).","journal-title":"Saudi Pharm. J."},{"key":"41232_CR44","doi-asserted-by":"publisher","first-page":"108051","DOI":"10.1016\/j.compbiolchem.2024.108051","volume":"110","author":"S Banerjee","year":"2024","unstructured":"Banerjee, S., Jana, S., Jha, T., Ghosh, B. & Adhikari, N. An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches. Comput. Biol. Chem. 110, 108051. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108051 (2024).","journal-title":"Comput. Biol. Chem."},{"key":"41232_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/1062936X.2024.2389822","volume":"35","author":"SK Baidya","year":"2024","unstructured":"Baidya, S. K., Banerjee, S., Ghosh, B., Jha, T. & Adhikari, N. Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl\/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis. SAR QSAR Environ. Res. 35, 665\u2013692. https:\/\/doi.org\/10.1080\/1062936X.2024.2389822 (2024).","journal-title":"SAR QSAR Environ. Res."},{"key":"41232_CR46","doi-asserted-by":"publisher","unstructured":"Wang, X., Chen, R., Liu, J., Wang, E. & Luo, H. Liver injury related to vascular endothelial growth factor tyrosine kinase inhibitors: A pharmacovigilance analysis of the USA FDA adverse event reporting system (FAERS) database. Expert Opin. Drug Saf. 1\u20139. https:\/\/doi.org\/10.1080\/14740338.2025.2460449 (2025).","DOI":"10.1080\/14740338.2025.2460449"},{"key":"41232_CR47","doi-asserted-by":"publisher","unstructured":"Elkaeed, E. B. et al. Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27196203 (2022).","DOI":"10.3390\/molecules27196203"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41232-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:02:59Z","timestamp":1775775779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41232-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41232"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41232-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. This research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11848"}}